Publications

University of Houston — COVID-19 Nasal Vaccine Candidate Effective at Preventing Disease Transmission

Single-dose intranasal vaccination elicits systemic and mucosal immunity against SARS-CoV-2

There have been 7m-13m excess deaths worldwide during the pandemic

Single-dose intranasal vaccination elicits systemic and mucosal immunity against SARS-CoV-2

Prioritizing diseases for research and development in emergency contexts

Billions will not receive a COVID-19 vaccine in 2021

Pfizer and BioNTech Report Evidence That Their Vaccine Is Effective Against COVID-19 Variant

UK to 'look carefully' at claims vaccine efficacy in Israel has dropped to 33 per cent with one dose

U.K. begins large trial of new COVID-19 treatment inhaled into the lungs

Monoclonal antibodies: 'great hope' in Covid treatments fails against variants

SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma

Covid: Vaccinated people may spread virus, says Van-Tam

Most poor nations 'will take until 2024 to achieve mass Covid-19 immunisation'

Novavax’s Vaccine Works Well — Except on Variant First Found in South Africa

Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K, and N501Y variants by BNT162b2 vaccine-elicited sera

Pfizer CEO vows to speed up vaccine development to under 100 days to combat the 'high likelihood' that current COVID-19 shots will need upgrades to stay effective

Coronavirus mutations add urgency to vaccination effort as experts warn of long battle ahead

High infection rate makes effort to contain Covid variants even more vital

SARS-CoV-2 Spike Protein Licensed by Oragenics from the NIH Demonstrates Protective Immunity in Mice

Vaxart shares fall 42% on disclosure of early-stage results from COVID-19 vaccine study

GSK and CureVac are making 'next-generation' vaccines that they say can tackle multiple COVID-19 variants at once

Interference between rhinovirus and influenza A virus: a clinical data analysis and experimental infection study

A Nasal Spray for the Common Cold Is Closer to Reality

New Israeli Covid drug which cured 30 cases of disease hailed by scientists as 'huge breakthrough'

Oxford Covid jab less effective against South African variant, study finds

Washington Post - Opinion: A virus locomotive is heading straight at us

Why the U.S. Is Underestimating Covid Reinfection

Johnson & Johnson CEO: Annual COVID shots may be necessary in year's ahead

Scientists Urge For Investment Now In Highly Potent Vaccines To Prevent The Next Pandemic

Show your support for high-impact reporting

The coronavirus is going to stick around forever. Get ready for the new normal.

Antiseptic nasal sprays and mouthwash show promise in preventing COVID-19 infections

Intranasal Approaches Have Potential As Vaccines & Therapies for COVID-19

As Covid-19 Vaccines Raise Hope, Cold Reality Dawns That Illness Is Likely Here to Stay

Emergence in late 2020 of multiple lineages of SARS-CoV-2 Spike protein variants affecting amino acid position 677

Inhaling away the virus: Is the next generation of COVID vaccines on its way?

Aduro stung as Novartis drops work on STING drug

Antibody Resistance of SARS-CoV-2 Variants

As Covid-19 Vaccines Raise Hope, Cold Reality Dawns That Illness Is Likely Here to Stay

Immunome stock more than triples after isolating antibodies in treatment of COVID-19 variants

Neutralizing Activity of BNT162b2-Elicited Serum — Preliminary Report

Where Are the Therapeutics to Combat COVID-19?

Altimmune's AdCOVID Vaccine Gets Positive FDA Update

Altimmune Video Presentation

COVID-19 Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenoviral-COVID-19 in Normal Healthy Volunteers

Acquisition of the L452R mutation in the ACE2-binding interface of Spike protein triggers recent massive expansion of SARS-Cov-2 variants

Coronavirus Variants and Mutations Tracker

BHARAT BIOTECH’S INTRANASAL VACCINE FOR COVID-19: EVERYTHING WE KNOW SO FAR ABOUT BBV154

Immunity to SARS-CoV-2 variants of concern

SARS-CoV-2 501Y.V2 (B.1.351) elicits cross-reactive neutralizing antibodies

Moderna expects Phase 1 data for multivalent Coronavirus Vaccine sooner than May

Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity

Assemblies-of-putative-SARS-CoV2-spike-encoding-mRNA-sequences-for-vaccines-BNT-162b2-and-mRNA-1273

Pfizer in vaccine supply talks with India